Fig. 1From: A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPDStudy design. PFT Pulmonary function test, Rx TreatmentBack to article page